Drugs / D-methadone
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00588640 | Oct 2004 → Jul 2008 | breast cancer, central nervous system cancer, colorectal cancer, esophageal cancer +5 | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04145674 | Oct 2022 → Dec 2026 | restless legs syndrome | Mauro Manconi | Suspended | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | D-methadone | “Drug: D-methadone” NCT00588640 ↗ |